Mechanism of drug release from double-walled PDLLA(PLGA) microspheres.

Qingxing Xu, Shi En Chin, Chi-Hwa Wang, Daniel W Pack
Author Information
  1. Qingxing Xu: Department of Chemical and Biomolecular Engineering, University of Illinois, 600 S. Mathews Avenue, Urbana, IL 61801, USA.

Abstract

The drug release and degradation behavior of two double-walled microsphere formulations consisting of a doxorubicin-loaded poly(d,l-lactic-co-glycolic acid) (PLGA) core (∼46 kDa) surrounded by a poly(d,l-lactic acid) (PDLLA) shell layer (∼55 and 116 kDa) were examined. It was postulated that different molecular weights of the shell layer could modulate the erosion of the outer coating and limit the occurrence of water penetration into the inner drug-loaded core on various time scales, and therefore control the drug release from the microspheres. For both microsphere formulations, the drug release profiles were observed to be similar. The degradation of the microspheres was monitored for a period of about nine weeks and analyzed using scanning electron microscopy, laser scanning confocal microscopy, and gel permeation chromatography. Interestingly, both microsphere formulations exhibited occurrence of bulk erosion of PDLLA on a similar time scale despite different PDLLA molecular weights forming the shell layer. The shell layer of the double-walled microspheres served as an effective diffusion barrier during the initial lag phase period and controlled the release rate of the hydrophilic drug independent of the molecular weight of the shell layer.

References

Int J Pharm. 2011 Aug 30;415(1-2):34-52 [PMID: 21640806]
J Control Release. 2003 Apr 29;89(2):167-77 [PMID: 12711441]
J R Soc Interface. 2008 Oct 6;5(27):1255-61 [PMID: 18647737]
Nature. 1994 Jan 20;367(6460):258-60 [PMID: 8121490]
J Biomater Sci Polym Ed. 1994;6(3):297-311 [PMID: 7527250]
J Biomed Mater Res A. 2004 Sep 15;70(4):576-84 [PMID: 15307162]
Int J Pharm. 2009 Jun 5;374(1-2):90-5 [PMID: 19446764]
Int J Pharm. 2005 Sep 14;301(1-2):294-303 [PMID: 16051452]
J Control Release. 2004 Apr 16;96(1):101-11 [PMID: 15063033]
J Pharm Sci. 2005 Sep;94(9):2013-22 [PMID: 16052542]
Adv Drug Deliv Rev. 2002 Oct 16;54(7):1015-39 [PMID: 12384319]
Biomaterials. 2010 Nov;31(33):8732-40 [PMID: 20709388]
J Mater Sci Mater Med. 2012 Jan;23(1):81-8 [PMID: 22127404]
Biomaterials. 1998 Nov;19(21):1973-80 [PMID: 9863531]
Colloids Surf B Biointerfaces. 2011 Jan 1;82(1):104-10 [PMID: 20846834]
Biomaterials. 1998 Nov;19(21):1981-8 [PMID: 9863532]
J Colloid Interface Sci. 2005 Nov 1;291(1):135-43 [PMID: 15964579]
J Biomed Mater Res A. 2010 Dec 1;95(3):709-16 [PMID: 20725974]
Macromol Rapid Commun. 2010 Jul 1;31(13):1193-200 [PMID: 21590875]
J Control Release. 2003 Mar 7;88(2):201-13 [PMID: 12628328]
J Biomed Mater Res. 1994 Dec;28(12):1465-75 [PMID: 7876286]
J Control Release. 2010 Oct 15;147(2):193-201 [PMID: 20647022]
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):552-6 [PMID: 8421690]
Biomaterials. 1995 Oct;16(15):1123-30 [PMID: 8562787]
Acta Biomater. 2012 Jul;8(6):2271-8 [PMID: 22342827]
J Control Release. 2007 Oct 8;122(3):338-44 [PMID: 17644208]
J Control Release. 2004 Jan 8;94(1):163-75 [PMID: 14684280]
J Control Release. 2002 Oct 30;83(3):437-52 [PMID: 12387951]

Grants

  1. R01 EB005181/NIBIB NIH HHS
  2. 1R01EB005181/NIBIB NIH HHS

MeSH Term

Doxorubicin
Drug Compounding
Fluorescence
Lactic Acid
Microscopy, Electron, Scanning
Microspheres
Molecular Weight
Optical Imaging
Polyglycolic Acid
Polylactic Acid-Polyglycolic Acid Copolymer
Porosity
Rheology
Time Factors

Chemicals

Polylactic Acid-Polyglycolic Acid Copolymer
Polyglycolic Acid
Lactic Acid
Doxorubicin